Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 14, Issue 5, Pages 473-480
Publisher
Springer Nature
Online
2014-04-22
DOI
10.1038/tpj.2014.14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
- (2012) V L Yip et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- (2011) Sae-Hoon Kim et al. EPILEPSY RESEARCH
- Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients
- (2011) Yan Zhang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
- (2011) Choong-Chor Chang et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Pharmacogenetics of cutaneous adverse drug reactions
- (2011) Michiko AIHARA JOURNAL OF DERMATOLOGY
- Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland
- (2011) Qian Wang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
- (2011) Kongkiat Kulkantrakorn et al. Pain Practice
- Question 2 Should phenytoin and carbamazepine be avoided in Asian populations with the HLA-B*1502 positive genetic variant?
- (2010) S. Ganesan et al. ARCHIVES OF DISEASE IN CHILDHOOD
- HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
- (2010) Nahoko Kaniwa et al. EPILEPSIA
- Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
- (2010) Wichittra Tassaneeyakul et al. EPILEPSIA
- Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China
- (2010) X.T. Wu et al. EPILEPSY & BEHAVIOR
- Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients
- (2010) Mariko KASHIWAGI et al. JOURNAL OF DERMATOLOGY
- HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
- (2009) Hiroko Ikeda et al. EPILEPSIA
- Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong Indians
- (2009) TimirY Mehta et al. Indian Journal of Dermatology Venereology & Leprology
- Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
- (2008) Chaichon Locharernkul et al. EPILEPSIA
- Currents in Contemporary Ethics for Asians Only? The Perils of Ancestry-Based Drug Prescribing
- (2008) Perry W. Payne JOURNAL OF LAW MEDICINE & ETHICS
- HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis
- (2008) Nahoko Kaniwa et al. PHARMACOGENOMICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started